Literature DB >> 16711028

Effect of shRNA inhibiting HiF1alpha gene on TIMP1 expression in RPE cells.

Cheng Yang1, Shuiqing Zeng, Mingliang Lv.   

Abstract

Small hairpin RNA (shRNA) was used to silence the HIF1alpha gene in human retinal pigment epithelial cells (RPE) under hypoxia in order to observe the effect of gene silencing on the expression of matrix metalloproteinase tissue inhibitor 1 (TIMP1). By using chemical hypoxic inducer CoCl2, to mimic RPE hypoxic environment, shRNA against the targeting region of HIF1alpha mRNA sequence was synthesized by a method of in vitro transcription, and the HIF1alpha was interfered in RPE cultured under hypoxia (induced by 150 micromol/L CoCl2). RT-PCR was employed to detect the expression of HIF1alpha and TIMP1. The expression levels of HIF1alpha and TIMP1 were measured by using Western blotting. The results showed that after the RPE were transfected with specific shRNA against HIF1alpha mRNA, RT-PCR revealed that under hypoxia, the efficacy of HIF1alpha gene silencing in RPE was 83.4%. Western blotting revealed that the expression levels of HIF1alpha protein was dramatically dropped. In addition. RT-PCR results demonstrated that the expression of TIMP1 mRNA was decreased by 28.9%, and the expression levels of TIMP1 protein were also significantly reduced by Western blotting. It was suggested that shRNA targeted against HIF1alpha mRNA could effectively silence the HIF1alpha gene, subsequently effectively inhibit the hypoxia-induced up-regulation of TIMP1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16711028     DOI: 10.1007/bf02828060

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Oxygen tension regulates the expression of a group of procollagen hydroxylases.

Authors:  Karl-Heinz Hofbauer; Bernhard Gess; Christiane Lohaus; Helmut E Meyer; Dörte Katschinski; Armin Kurtz
Journal:  Eur J Biochem       Date:  2003-11

Review 2.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

3.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

4.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells.

Authors:  Nan Sook Lee; Taikoh Dohjima; Gerhard Bauer; Haitang Li; Ming-Jie Li; Ali Ehsani; Paul Salvaterra; John Rossi
Journal:  Nat Biotechnol       Date:  2002-05       Impact factor: 54.908

5.  Hypoxia promotes fibrogenesis in human renal fibroblasts.

Authors:  J T Norman; I M Clark; P L Garcia
Journal:  Kidney Int       Date:  2000-12       Impact factor: 10.612

6.  Carcinogenic metals induce hypoxia-inducible factor-stimulated transcription by reactive oxygen species-independent mechanism.

Authors:  K Salnikow; W Su; M V Blagosklonny; M Costa
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

  6 in total
  3 in total

1.  Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.

Authors:  Mei Huang; Patricia Nguyen; Fangjun Jia; Shijun Hu; Yongquan Gong; Patricia E de Almeida; Li Wang; Divya Nag; Mark A Kay; Amato J Giaccia; Robert C Robbins; Joseph C Wu
Journal:  Circulation       Date:  2011-09-13       Impact factor: 29.690

2.  The role of hypoxia inducible factor-1α in the increased MMP-2 and MMP-9 production by human monocytes exposed to nickel nanoparticles.

Authors:  Rong Wan; Yiqun Mo; Sufan Chien; Yihua Li; Yixin Li; David J Tollerud; Qunwei Zhang
Journal:  Nanotoxicology       Date:  2011-03-14       Impact factor: 5.913

3.  TIMP-1-expressing breast tumor spheroids for the evaluation of drug penetration and efficacy.

Authors:  In Yeong Bae; Wooshik Choi; Seung Ja Oh; Chansoo Kim; Sang-Heon Kim
Journal:  Bioeng Transl Med       Date:  2021-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.